You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

List of Excipients in API fenfluramine

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing fenfluramine

Subscribe to access the full database, or Subscribe
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
UCB Inc	FINTEPLA	fenfluramine	43376-322	ANHYDROUS CITRIC ACID	2038-12-29
UCB Inc	FINTEPLA	fenfluramine	43376-322	ETHYLPARABEN	2038-12-29
UCB Inc	FINTEPLA	fenfluramine	43376-322	HYDROXYETHYL CELLULOSE	2038-12-29
UCB Inc	FINTEPLA	fenfluramine	43376-322	METHYLPARABEN	2038-12-29
UCB Inc	FINTEPLA	fenfluramine	43376-322	POTASSIUM CITRATE	2038-12-29
UCB Inc	FINTEPLA	fenfluramine	43376-322	SUCRALOSE	2038-12-29
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for fenfluramine

Excipient focus: ANHYDROUS CITRIC ACID

fenfluramine drug variants containing ANHYDROUS CITRIC ACID

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
UCB Inc	fenfluramine	43376-322
>Company	>Ingredient	>NDC

fenfluramine drug variants not containing ANHYDROUS CITRIC ACID

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: ETHYLPARABEN

fenfluramine drug variants containing ETHYLPARABEN

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
UCB Inc	fenfluramine	43376-322
>Company	>Ingredient	>NDC

fenfluramine drug variants not containing ETHYLPARABEN

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYDROXYETHYL CELLULOSE

fenfluramine drug variants containing HYDROXYETHYL CELLULOSE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
UCB Inc	fenfluramine	43376-322
>Company	>Ingredient	>NDC

fenfluramine drug variants not containing HYDROXYETHYL CELLULOSE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: METHYLPARABEN

fenfluramine drug variants containing METHYLPARABEN

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
UCB Inc	fenfluramine	43376-322
>Company	>Ingredient	>NDC

fenfluramine drug variants not containing METHYLPARABEN

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POTASSIUM CITRATE

fenfluramine drug variants containing POTASSIUM CITRATE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
UCB Inc	fenfluramine	43376-322
>Company	>Ingredient	>NDC

fenfluramine drug variants not containing POTASSIUM CITRATE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SUCRALOSE

fenfluramine drug variants containing SUCRALOSE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
UCB Inc	fenfluramine	43376-322
>Company	>Ingredient	>NDC

fenfluramine drug variants not containing SUCRALOSE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: WATER

fenfluramine drug variants containing WATER

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
UCB Inc	fenfluramine	43376-322
>Company	>Ingredient	>NDC

fenfluramine drug variants not containing WATER

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.